Literature DB >> 23712453

SNP-based non-invasive prenatal testing detects sex chromosome aneuploidies with high accuracy.

Carole Samango-Sprouse1, Milena Banjevic, Allison Ryan, Styrmir Sigurjonsson, Bernhard Zimmermann, Matthew Hill, Megan P Hall, Margaret Westemeyer, Jennifer Saucier, Zachary Demko, Matthew Rabinowitz.   

Abstract

OBJECTIVE: This study aimed to develop a single-nucleotide polymorphism-based and informatics-based non-invasive prenatal test that detects sex chromosome aneuploidies early in pregnancy.
METHODS: Sixteen aneuploid samples, including thirteen 45,X, two 47,XXY, and one 47,XYY, along with 185 euploid controls, were analyzed. Cell-free DNA was isolated from maternal plasma, amplified in a single multiplex polymerase chain reaction assay that targeted 19,488 polymorphic loci covering chromosomes 13, 18, 21, X, and Y, and sequenced. Sequencing results were analyzed using a Bayesian-based maximum likelihood statistical method to determine copy number of interrogated chromosomes, calculating sample-specific accuracies.
RESULTS: Of the samples that passed a stringent quality control metric (93%), the algorithm correctly identified copy number at all five chromosomes in all but one of the 187 samples, for 934/935 correct calls as early as 9.4 weeks of gestation. We detected 45,X with 91.7% sensitivity (CI: 61.5-99.8%) and 100% specificity (CI: 97.9-100%), and 47,XXY and 47,XYY. The average calculated accuracy was 99.78%.
CONCLUSION: This method non-invasively detected 45,X, 47,XXY, and 47,XYY fetuses from cell-free DNA isolated from maternal plasma with high calculated accuracies and thus offers a non-invasive method with the potential to function as a routine screen allowing for early prenatal detection of rarely diagnosed yet commonly occurring sex aneuploidies.
© 2013 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23712453      PMCID: PMC3764608          DOI: 10.1002/pd.4159

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  42 in total

1.  Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood.

Authors:  Amy J Sehnert; Brian Rhees; David Comstock; Eileen de Feo; Gabrielle Heilek; John Burke; Richard P Rava
Journal:  Clin Chem       Date:  2011-04-25       Impact factor: 8.327

2.  Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18.

Authors:  Andrew B Sparks; Craig A Struble; Eric T Wang; Ken Song; Arnold Oliphant
Journal:  Am J Obstet Gynecol       Date:  2012-01-26       Impact factor: 8.661

3.  Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18.

Authors:  Ghalia Ashoor; Argyro Syngelaki; Marion Wagner; Cahit Birdir; Kypros H Nicolaides
Journal:  Am J Obstet Gynecol       Date:  2012-01-24       Impact factor: 8.661

4.  Targeted massively parallel sequencing of maternal plasma DNA permits efficient and unbiased detection of fetal alleles.

Authors:  Gary J W Liao; Fiona M F Lun; Yama W L Zheng; K C Allen Chan; Tak Y Leung; Tze K Lau; Rossa W K Chiu; Y M Dennis Lo
Journal:  Clin Chem       Date:  2010-11-15       Impact factor: 8.327

5.  Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting.

Authors:  Mathias Ehrich; Cosmin Deciu; Tricia Zwiefelhofer; John A Tynan; Lesley Cagasan; Roger Tim; Vivian Lu; Ron McCullough; Erin McCarthy; Anders O H Nygren; Jarrod Dean; Lin Tang; Don Hutchison; Tim Lu; Huiquan Wang; Vach Angkachatchai; Paul Oeth; Charles R Cantor; Allan Bombard; Dirk van den Boom
Journal:  Am J Obstet Gynecol       Date:  2011-02-18       Impact factor: 8.661

6.  Growth hormone treatment before the age of 4 years prevents short stature in young girls with Turner syndrome.

Authors:  A Linglart; S Cabrol; P Berlier; C Stuckens; K Wagner; M de Kerdanet; C Limoni; J-C Carel; J-L Chaussain
Journal:  Eur J Endocrinol       Date:  2011-03-11       Impact factor: 6.664

7.  DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study.

Authors:  Glenn E Palomaki; Edward M Kloza; Geralyn M Lambert-Messerlian; James E Haddow; Louis M Neveux; Mathias Ehrich; Dirk van den Boom; Allan T Bombard; Cosmin Deciu; Wayne W Grody; Stanley F Nelson; Jacob A Canick
Journal:  Genet Med       Date:  2011-11       Impact factor: 8.822

8.  Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy.

Authors:  Andrew B Sparks; Eric T Wang; Craig A Struble; Wade Barrett; Renee Stokowski; Celeste McBride; Jacob Zahn; Kevin Lee; Naiping Shen; Jigna Doshi; Michel Sun; Jill Garrison; Jay Sandler; Desiree Hollemon; Patrick Pattee; Aoy Tomita-Mitchell; Michael Mitchell; John Stuelpnagel; Ken Song; Arnold Oliphant
Journal:  Prenat Diagn       Date:  2012-01-06       Impact factor: 3.050

9.  Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing.

Authors:  Eric Z Chen; Rossa W K Chiu; Hao Sun; Ranjit Akolekar; K C Allen Chan; Tak Y Leung; Peiyong Jiang; Yama W L Zheng; Fiona M F Lun; Lisa Y S Chan; Yongjie Jin; Attie T J I Go; Elizabeth T Lau; William W K To; Wing C Leung; Rebecca Y K Tang; Sidney K C Au-Yeung; Helena Lam; Yu Y Kung; Xiuqing Zhang; John M G van Vugt; Ryoko Minekawa; Mary H Y Tang; Jun Wang; Cees B M Oudejans; Tze K Lau; Kypros H Nicolaides; Y M Dennis Lo
Journal:  PLoS One       Date:  2011-07-06       Impact factor: 3.240

10.  DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study.

Authors:  Glenn E Palomaki; Cosmin Deciu; Edward M Kloza; Geralyn M Lambert-Messerlian; James E Haddow; Louis M Neveux; Mathias Ehrich; Dirk van den Boom; Allan T Bombard; Wayne W Grody; Stanley F Nelson; Jacob A Canick
Journal:  Genet Med       Date:  2012-02-02       Impact factor: 8.822

View more
  39 in total

Review 1.  Next-generation molecular diagnosis: single-cell sequencing from bench to bedside.

Authors:  Wanjun Zhu; Xiao-Yan Zhang; Sadie L Marjani; Jialing Zhang; Wengeng Zhang; Shixiu Wu; Xinghua Pan
Journal:  Cell Mol Life Sci       Date:  2016-10-13       Impact factor: 9.261

Review 2.  Prenatal and pre-implantation genetic diagnosis.

Authors:  Joris Robert Vermeesch; Thierry Voet; Koenraad Devriendt
Journal:  Nat Rev Genet       Date:  2016-09-15       Impact factor: 53.242

Review 3.  Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women.

Authors:  Mylène Badeau; Carmen Lindsay; Jonatan Blais; Leon Nshimyumukiza; Yemisi Takwoingi; Sylvie Langlois; France Légaré; Yves Giguère; Alexis F Turgeon; William Witteman; François Rousseau
Journal:  Cochrane Database Syst Rev       Date:  2017-11-10

Review 4.  Integration of noninvasive DNA testing for aneuploidy into prenatal care: what has happened since the rubber met the road?

Authors:  Diana W Bianchi; Louise Wilkins-Haug
Journal:  Clin Chem       Date:  2013-11-19       Impact factor: 8.327

Review 5.  Have we done our last amniocentesis? Updates on cell-free DNA for Down syndrome screening.

Authors:  Kathryn J Gray; Louise E Wilkins-Haug
Journal:  Pediatr Radiol       Date:  2018-03-17

Review 6.  Cell-Free DNA Screening: Complexities and Challenges of Clinical Implementation.

Authors:  Matthew R Grace; Emily Hardisty; Sarah K Dotters-Katz; Neeta L Vora; Jeffrey A Kuller
Journal:  Obstet Gynecol Surv       Date:  2016-08       Impact factor: 2.347

7.  Single Nucleotide Polymorphism-Based Analysis of Cell-Free Fetal DNA in 3000 Cases from Germany and Austria.

Authors:  B Eiben; M Krapp; H Borth; N Kutur; P Kreiselmaier; R Glaubitz; J Deutinger; E Merz
Journal:  Ultrasound Int Open       Date:  2015-06-26

8.  Single Nucleotide Polymorphism-Based Noninvasive Prenatal Testing: Experience in India.

Authors:  Ishwar Chander Verma; Ratna Puri; Eswarachary Venkataswamy; Tulika Tayal; Sheela Nampoorthiri; Chitra Andrew; Madhulika Kabra; Rashmi Bagga; Mamatha Gowda; Meenu Batra; Sridevi Hegde; Anita Kaul; Neerja Gupta; Pallavi Mishra; Jayshree Ganapathi Subramanian; Shruti Lingaiah; Riyaz Akhtar; Francis Kidangan; R Chandran; C Kiran; G R Ravi Kumar; V L Ramprasad; Priya Kadam
Journal:  J Obstet Gynaecol India       Date:  2018-01-25

Review 9.  Too much, too soon?: Commercial provision of noninvasive prenatal screening for subchromosomal abnormalities and beyond.

Authors:  Megan Allyse; Subhashini Chandrasekharan
Journal:  Genet Med       Date:  2015-03-19       Impact factor: 8.822

10.  Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics.

Authors:  Anthony R Gregg; Brian G Skotko; Judith L Benkendorf; Kristin G Monaghan; Komal Bajaj; Robert G Best; Susan Klugman; Michael S Watson
Journal:  Genet Med       Date:  2016-07-28       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.